Column Group LLC Tenaya Therapeutics, Inc. Transaction History
Column Group LLC
- $44.2 Million
- Q1 2025
A detailed history of Column Group LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Column Group LLC holds 9,400,290 shares of TNYA stock, worth $8.18 Million. This represents 12.12% of its overall portfolio holdings.
Number of Shares
9,400,290
Previous 9,400,290
-0.0%
Holding current value
$8.18 Million
Previous $13.4 Million
60.14%
% of portfolio
12.12%
Previous 24.12%
Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Casdin Capital, LLC New York, NY6.73MShares$5.86 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$5.15 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$3.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$3.54 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$1.96 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $36M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...